Abstract
Introduction Substance use affects physical health, mental health, causes social, economic damage in their family environment and society. In recent decades this has changed.
Aim To determine the perception of the consumption of legal and illegal substances and related factors in the general Honduran population.
Methodology Analytical cross-sectional study, through an active search, the information was provided by a suitable informant ≥ 18 years of age, both sexes. Direct questions were asked about consumption, this was associated to influential variables, through descriptive and analytical statistics. Results: Of the 3309 participants distributed nationally, When multivariate analysis was performed, it was found that there was a greater perception of problematic drug use when there was a history of previous violence (aPR: 1.53; 95%CI: 1.22-1.92; p-value<0.001), if cannabis had been consumed in the last quarter (aPR: 1.29; 95%CI: 1.05-1.58; p-value=0.016), if she stopped doing what was expected (aPR : 7.05; 95%CI: 5.00-9.95; p-value<0.001) or if she worried a friend or family member (aPR: 1.49; 95%CI: 1.20-1.86; p-value<0.001), on the contrary, there was less concern among those with university studies (aPR: 0.70; 95%CI: 0.49-0.99; p-value=0.048), adjusted for six variables.
Discussion An association was found between the perception of problematic substance use according to sex, academic grade, history of previous violence, use of tobacco, cannabis, cocaine, opioids, hallucinogens, whether the person stopped doing what was expected, whether a friend or relative was concerned, or whether the person injected.
Conclusion The most reported legal substance of use among the Honduran population was tobacco, followed by marijuana and cocaine among illegal substances.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The current article processing charges (publication fees) were funded by the Facultad de Ciencias Medicas (FCM) (2-03-01-01), Universidad Nacional Autonoma de Honduras (UNAH), Tegucigalpa, MDC, Honduras, Central America (granted to Dra. Espinoza).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study project was approved by the Biomedical Research Ethics Committee (CEIB) of the FCM IRB 00003070, approved in the session of November 22 of 2018, with registration number: 047-2018
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability Statement
The data presented in this study are available on request from the corresponding author.
